Archemix in Yet Another Deal for its Aptamer Technology
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 99 (Table of Contents)
Published: 8 Aug-2008
DOI: 10.3833/pdr.v2008.i99.146 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Archemix’s expertise and extensive IP portfolio, associated with the discovery and development of aptamers, has resulted in its latest agreement with the Japanese company, Ribomic...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS